| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |